Skip to main content

Closed

JANX: Janux Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

13thpctl

Volume

0.46×avg

Market Cap

925.13MUSD

P/E Ratio

-8.5TTM

Div Yield

-ann

Janux Therapeutics, Inc.

JANXNASDAQ Global Market·USD·Closed

Janux Therapeutics, Inc.

JANXNASDAQ·USD·Closed

$15.17

−2.63%

$15.17

−$0.41 (2.63%)

52W Range

13thpctl

Volume

0.46×avg

Mkt Cap

925.13MUSD

P/E

-8.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings